Left Menu
Development News Edition

Spain, Turkey reject China’s faulty testing kits over incorrect results

Devdiscourse News Desk | Madrid | Updated: 28-03-2020 02:09 IST | Created: 28-03-2020 02:09 IST
Spain, Turkey reject China’s faulty testing kits over incorrect results
The Spanish government is forced to return ‘faulty’ coronavirus testing kits to China over inaccurate results. Image Credit: Twitter(@SAgovnews)

The inaccuracy of Chinese technological products are not new to anyone over the planet. Still country's like Spain and Turkey expected to depend on China's technological assistance during the severe battle against coronavirus epidemic.

But China, in sooth, watered their expectations. The Spanish government is forced to return 'faulty' coronavirus testing kits to China over inaccurate results. The Spanish ministry, according to Daily Mail, has recently said that it would withdraw the kits as the kits supplied by the company Shenzhen Bioeasy were defective and did not correctly diagnose people when tested at hospitals.

The Health Minister of Spane, Salvador Illa announced earlier this week that the country had bought USD 467 million in medical supplies from China, including 950 ventilators, 5.5 million testing kits, 11 million gloves and more than half a billion protective face masks.

According to the claims, China is apparently trying to fill the void of American leadership in Europe during the coronavirus crisis as Chinese public officials work to shift the blame of the virus from China to other countries including America.

Same happened with Turkey. The government of Turkey has put aside a sample of Chinese-made Covid-19 rapid testing kits after discovering that those are having mastery of providing inaccurate results.

"We have received some samples from the company. We didn't find them viable and ordered some other testing kit models from a separate Chinese company," a Turkish official confirmed to Middle East Eye.


TRENDING

OPINION / BLOG / INTERVIEW

Socio-economic Impact of Covid-19 on Women

Today, women and girls are facing a double whammy - their sources of income have dried up but the workload has increased. There is a great need for gender-sensitive policies to recover from the pandemic. ...

Tracking Cybersecurity: Laying the groundwork for tougher regulations post-COVID 19

The changes indicate that the tech industry is moving towards a paradigm shift over how it operates and, more importantly, how it is regulated....

Tax dodging in rich and poor countries alike, wealthy taxpayers often outwit the taxman

... ...

COVID-19 threatens to widen the digital gender divide

In a world that, all of sudden, has turned virtual, it has become absolutely essential to providing equal digital access and opportunities to the unconnected population, primarily dominated by women. ...

Videos

Latest News

Bangladesh players arrange pure water for Amphan-hit people

Bangladesh cricket team members, led by ODI captain Tamim Iqbal, have extended their helping hand to the sufferers of cyclone Amphan that hit the country last month amid the COVID-19 pandemicTamim arranged for pure water for the inhabitants...

Tamil Nadu government caps charges in private hospitals for COVID-19 treatment at Rs 15,000 per day in ICUs, in general ward the maximum is Rs 7,500: Govt.

Tamil Nadu government caps charges in private hospitals for COVID-19 treatment at Rs 15,000 per day in ICUs, in general ward the maximum is Rs 7,500 Govt....

Afghans condemn Iranian police after refugees killed in car blaze

Afghans have taken to social media to denounce Iranian police after a video of a car carrying with Afghan refugees set ablaze in Iran went viral, arousing new anger weeks after Afghan officials accused Iranian border guards of drowning migr...

Science News Roundup: Tyson the alpaca takes heavyweight role in search for coronavirus vaccine; Does drug touted by Trump work on COVID-19? and more

Following is a summary of current science news briefs.Does drug touted by Trump work on COVID-19 After data debacle, we still dont knowScientists are resuming COVID-19 trials of the now world-famous drug hydroxychloroquine, as confusion con...

Give Feedback